Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis

NCT07187661 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia
Chronic Synovitis

Interventions

DRUG: Intra-articular Bevacizumab

Sponsor

Khyber Medical University Peshawar